series-c-plus
Stage
1
Investors
About
Clinical-stage biopharmaceutical company developing small-molecule targeted therapies for oncology indications.
Explore Prelude Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.